14,15-epoxy-5,8,11-eicosatrienoic acid has been researched along with Cerebral Infarction, Middle Cerebral Artery in 1 studies
14,15-epoxy-5,8,11-eicosatrienoic acid: RN given refers to cpd without isomeric designation
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Y | 1 |
| Wan, Y | 1 |
| Fang, Y | 1 |
| Yao, E | 1 |
| Xu, S | 1 |
| Ning, Q | 1 |
| Zhang, G | 1 |
| Wang, W | 1 |
| Huang, X | 1 |
| Xie, M | 1 |
1 other study available for 14,15-epoxy-5,8,11-eicosatrienoic acid and Cerebral Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Epoxyeicosanoid Signaling Provides Multi-target Protective Effects on Neurovascular Unit in Rats After Focal Ischemia.
Topics: 8,11,14-Eicosatrienoic Acid; Adamantane; Animals; Apoptosis; Epoxide Hydrolases; Infarction, Middle | 2016 |